4//SEC Filing
Mosseri Marlio Charles 4
Accession 0001104659-25-103522
CIK 0001875558other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:00 AM ET
Size
8.7 KB
Accession
0001104659-25-103522
Insider Transaction Report
Form 4
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$6.06/sh+46,900$284,214→ 3,028,706 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-10-24$6.15/sh+35,034$215,459→ 3,063,740 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-10-27$6.28/sh+72,836$457,410→ 3,136,576 total(indirect: By Emerald Hill Ventures SARL SPF.)
Holdings
- 109,321
Common Stock
Footnotes (1)
- [F1]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001806384
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 8:00 AM ET
- Size
- 8.7 KB